Double blind study of ispaghula in irritable bowel syndrome.
Open Access
- 1 November 1987
- Vol. 28 (11) , 1510-1513
- https://doi.org/10.1136/gut.28.11.1510
Abstract
A double blind placebo controlled trial of ispaghula husk in 80 patients with irritable bowel syndrome is reported. Global assessment judged treatment to be satisfactory in 82% of patients receiving ispaghula and 53% of the placebo group (p less than 0.02). Bowel habit was unchanged in the placebo group, while constipation significantly improved in patients taking ispaghula (p = 0.026). Transit time decreased significantly in those taking ispaghula compared with placebo (p = 0.001), especially in patients with initially high transit times. Abdominal pain and bloating improved in both groups, with no significant differences between ispaghula and placebo. Four of the eight withdrawals on ispaghula and 10 of the 15 withdrawals on placebo were because of treatment failure. Ispaghula significantly improves overall well being in patients with irritable bowel syndrome, and in those with constipation favourably affects bowel habit and transit time.This publication has 11 references indexed in Scilit:
- Non-colonic features of irritable bowel syndrome.Gut, 1986
- The Effect of Coarse Wheat Bran in the Irritable Bowel Syndrome lA Double-Blind Cross-Over StudyScandinavian Journal of Gastroenterology, 1985
- The irritable bowel.Gut, 1984
- What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?Gut, 1984
- Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome.1983
- Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk.BMJ, 1979
- The irritable bowel syndrome. Part I: clinical spectrum.1977
- WHEAT FIBRE AND IRRITABLE BOWEL SYNDROMEThe Lancet, 1977
- A DOUBLE-BLIND TRIAL OF THE EFFECT OF WHEAT BRAN ON SYMPTOMS OF IRRITABLE BOWEL SYNDROMEThe Lancet, 1976
- A new method for studying gut transit times using radioopaque markersGut, 1969